ORBi: Detailed Reference

Article (Scientific journals)

L’endométriose est-elle une pathologie inflammatoire ?

Brichant, Géraldine; Moise, Alice; Nisolle, Michelle

2022 • In Revue Médicale de Liège, 77 (5-6), p. 370-376

Editorial Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/299423

PubMed
35657196

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Endometriosis as an inflammatory disease_20220506_19.pdf

Author postprint (325.13 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Immunity; Inflammation; Therapy; Endometriosis; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Pelvic Pain/drug therapy; Pelvic Pain/therapy; Uterus; Endometriosis/complications; Endometriosis/diagnosis; Endometriosis/therapy; Pelvic Pain; Medicine (all)

Abstract :

[en] Endometriosis is the presence of stromal and epithelial cells outside the uterine cavity. This chronic inflammatory disease affects about 10 % of the female population in reproductive age and is responsible for chronic pelvic pain and infertility. Its pathogenesis is complex, and the treatment will rely on medical treatment or/and surgery. Medical treatment consists in alleviating pain thanks to analgesic and hormonal treatment but none can eradicate the disease. Medical treatment often fails and about 10 % will add nonsteroid anti-inflammatory drugs to their hormonal treatment. Major role of immune/inflammatory cells in the disease makes them a promising tool for targeted therapy.
[fr] : L’endométriose est définie par la présence de cellules stromales et épithéliales endométriales en dehors de la cavité utérine. Considérée comme une pathologie inflammatoire chronique, elle touche environ 10 % des femmes en âge de procréer et est responsable de douleur pelvienne et d’infertilité. Sa pathologie est complexe et le traitement sera médical et/ou chirurgical. Le traitement médical consistera à soulager la douleur grâce à des antalgiques et une hormonothérapie, mais aucune des molécules utilisées actuellement ne permet l’éradication de l’endométriose. Le traitement médical échoue fréquemment. Il est estimé que 10 % des patientes ne seront pas soulagées par une hormonothérapie seule et nécessiteront le recours à des anti-inflammatoires. Le rôle prépondérant des cellules et cytokines inflammatoires dans la survenue de la maladie permet d’envisager des thérapies ciblées.

Disciplines :

Reproductive medicine (gynecology, andrology, obstetrics)

Author, co-author :

Brichant, Géraldine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR)

Moise, Alice ; Centre Hospitalier Universitaire de Liège - CHU > > Pool

Nisolle, Michelle ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique

Language :

French

Title :

L’endométriose est-elle une pathologie inflammatoire ?

Alternative titles :

[en] Endometriosis as an inflammatory disease ?

Publication date :

May 2022

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Revue Medicale de Liege, Belgium

Volume :

77

Issue :

5-6

Pages :

370-376

Peer reviewed :

Editorial Reviewed verified by ORBi

Available on ORBi :

since 27 January 2023

Statistics

Number of views

213 (15 by ULiège)

Number of downloads

914 (10 by ULiège)

More statistics

Scopus citations^®

3

Scopus citations^®
without self-citations

1

OpenAlex citations

2

Article has an altmetric score of 1

See more details

Bibliography

Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99.
Jamali N, Zal F, Mostafavi-Pour Z, et al. Ameliorative effects of quercetin and metformin and their combination against experimental endometriosis in rats. Reprod Sci 2021;28:683-92.
Miller JE, Ahn SH, Monsanto SP, et al. Implications of immune dysfunction on endometriosis associated infertility. Oncotarget 2017;8:7138-47.
Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-96.
Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril 2017;108:125-36.
Brichant G, Nervo P, Albert A, et al. Heterogeneity of estrogen receptor alpha and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments. Gynecol Endocrinol 2018;34:651-5.
Brichant G, Laraki I, Henry L, et al. New therapeutics in endometriosis: a review of hormonal, non-hormonal, and noncoding RNA treatments. Int J Mol Sci 2021;22:10498.
Van Langendonckt A, Casanas-Roux F, Donnez J, Oxidative stress and peritoneal endometriosis. Fertil Steril 2002;77:861-70
Santanam N, Murphy AA, Parthasarathy S. Macrophages, oxidation, and endometriosis. Ann N Y Acad Sci 2002;955:183-98; discussion 19-200, 396-406.
Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the pelvic cavity. Am J Obstet Gynecol 1927;14:422-69.
Nisolle M, Alvarez ML, Colombo M, Foidart JM. Pathogenesis of endometriosis. Gynecol Obstet Fertil 2007;35:898-903.
Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 2007;25:2082-6.
Velho RV, Taube E, Sehouli J, Mechsner S. Neurogenic inflammation in the context of endometriosis-what do we know? Int J l Mol Sci 2021;22:13102.
Ezzati M, Carr BR. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis- related pain. Womens health (Lond) 2015;11:19-28.
Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014;10:261-75.
Vallve-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update 2019;25:564-91.
Yeaman GR, Collins JE, Fanger MW, et al. CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 2001;102:434-40.
Jiang YP, Peng YQ, Wang L, et al. RNA-sequencing identifies differentially expressed genes in T helper 17 cells in peritoneal fluid of patients with endometriosis. J Reprod Immunol 2022;149:103453.
Capellino S, Montagna P, Villaggio B, et al. Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis. Ann N Y Acad Sci 2006;1069:263-7.
Kapoor R, Stratopoulou CA, Dolmans MM. Pathogenesis of endometriosis: new insights into prospective therapies. Int J Mol Sci 2021;22:11700.
Jeung I, Cheon K, Kim MR. Decreased cytotoxicity of peripheral and peritoneal natural killer cell in endometriosis. BioMed Res Int 2016;2016:2916070.
Mettler L, Volkov NI, Kulakov VI, et al. Lymphocyte subsets in the endometrium of patients with endometriosis throughout the menstrual cycle. Am J Reprod Immunol 1996;36:342-8.
Gogacz M, Winkler I, Bojarska-Junak A, et al. Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis. J Reprod Immunol 2016;117:39-44.
Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007;178:2572-8.
Tamura N, Maejima Y, Tezuka D, et al. Profiles of serum cytokine levels in Takayasu arteritis patients: potential utility as biomarkers for monitoring disease activity. J Cardiol 2017;70:278-85.
Chen S, Zhang J, Huang C, et al. Expression of the T regulatory cell transcription factor FoxP3 in peri-implantation phase endometrium in infertile women with endometriosis. Reprod Biol Endocrinol 2012;10:34.
Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010;10:490-500.
White HD, Crassi KM, Givan AL, et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997;158:3017-27.
Berbic M, Schulke L, Markham R, et al. Macrophage expression in endometrium of women with and without endometriosis. Hum Reprod 2009;24:325-32.
Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol 2013;4:9.
Nisolle M, Alvarez ML, Colombo M, Foidart JM. [Endometriosis: from research to clinical practice]. Bulletin et memoires de l'Academie Royale de Médecine de Belgique. 2007;162:263-72; discussion 73-4.
van Kaam KJ, Schouten JP, Nap AW, et al. Fibromuscular differentiation in deeply infiltrating endometriosis is a reaction of resident fibroblasts to the presence of ectopic endometrium. Hum Reprod 2008;23:2692-700.
Bernacchioni C, Capezzuoli T, Vannuzzi V, et al. Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor betainduced fibrosis. Fertil Steril 2021;115:501-11.
Norman RJ, Wu R. The potential danger of COX-2 inhibitors. Fertil Steril 2004;81:493-4.
Saunders PTK, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell 2021;184:2807-24.
Kato T, Yasuda K, Matsushita K, et al. Interleukin-1/-33 signaling pathways as therapeutic targets for endometriosis. Front Immunol 2019;10:2021.
Cavalli G, Dinarello CA. Anakinra therapy for non-cancer inflammatory diseases. Front Pharmacol 2018;9:1157.
Lu D, Song H, Shi G. Anti-TNF-alpha treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2013;3:CD008088.

Similar publications